JPS56500472A - - Google Patents

Info

Publication number
JPS56500472A
JPS56500472A JP50092580A JP50092580A JPS56500472A JP S56500472 A JPS56500472 A JP S56500472A JP 50092580 A JP50092580 A JP 50092580A JP 50092580 A JP50092580 A JP 50092580A JP S56500472 A JPS56500472 A JP S56500472A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50092580A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS56500472A publication Critical patent/JPS56500472A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/97—Test strip or test slide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP50092580A 1979-05-02 1980-04-30 Pending JPS56500472A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7911082A FR2455743A1 (fr) 1979-05-02 1979-05-02 Procede et dispositif pour le dosage des lipoproteines seriques

Publications (1)

Publication Number Publication Date
JPS56500472A true JPS56500472A (ja) 1981-04-09

Family

ID=9224942

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50092580A Pending JPS56500472A (ja) 1979-05-02 1980-04-30

Country Status (6)

Country Link
US (1) US4399217A (ja)
JP (1) JPS56500472A (ja)
FR (1) FR2455743A1 (ja)
GB (1) GB2061501B (ja)
SE (1) SE450861B (ja)
WO (1) WO1980002460A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS618665A (ja) * 1984-03-09 1986-01-16 コンパニ・オリ・アンデユストリ・ソシエテ・アノニム 抗原、抗体、またはハプテンの免疫検定法、この免疫検定法を用いたリポ蛋白質、およびα−フエトプロテインの検定法、およびこの検定法を実施する検定キツト

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2486657A1 (fr) * 1980-07-09 1982-01-15 Pasteur Institut Procede de detection et de dosage d'une substance biologique par erythroadsorption
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
JPS58221166A (ja) * 1982-06-18 1983-12-22 Mochida Pharmaceut Co Ltd 免疫化学的測定用担体および該担体を使用した測定試薬
DE3319066A1 (de) * 1983-05-26 1984-11-29 Claus-Christian Dr.Rer.Nat. Dr.Med. 6901 Wilhelmsfeld Heuck Verfahren und reagenz zum direkten nachweis eines analyts nach spezifischer entfernung von colloidpartikeln in waessrigen loesungen biologischer herkunft
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
US4654313A (en) * 1983-11-25 1987-03-31 The Washington University Methods for the determination of brain antigens
US4560504A (en) * 1984-12-06 1985-12-24 Uop Inc. Carboxyl anchored immobilized antibodies
US4970144A (en) * 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins
US4720455A (en) * 1985-09-06 1988-01-19 Pitman-Moore, Inc. Progesterone assay method for mammals and monoclonal antibody therefor
WO1988010430A1 (en) * 1985-12-27 1988-12-29 Arve Osland Determination of hdl2 and hdl3 concentration by use of extract from bacteria
WO1987006345A1 (en) * 1986-04-11 1987-10-22 Murex Corporation Colorimetric ratioing immunoassay
IL79945A (en) * 1986-09-04 1991-06-10 I D L International Diagnostic Method for the quantitative determination of total cholesterol in blood
US5126240A (en) * 1986-09-29 1992-06-30 Curtiss Linda K Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i
GB8717791D0 (en) * 1987-07-28 1987-09-03 Baralle F E Immunoassay method
AU6406390A (en) * 1989-08-24 1991-04-03 Ramsey Foundation Method and apparatus for the measurement of organic antigens
US5344571A (en) * 1992-02-18 1994-09-06 University Of Texas System Board Of Regents Method for separating isoanalytes and measuring analytes in fluids
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20030127386A1 (en) * 2001-06-25 2003-07-10 Bomberger David C. Hollow fiber contactor systems for removal of lipids from fluids
JP2004532709A (ja) * 2001-06-25 2004-10-28 リピド サイエンスィズ インコーポレイテッド 流体から脂質を除去するための溶媒を用いたシステムおよび方法
WO2003000372A2 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US20040106556A1 (en) * 2002-08-26 2004-06-03 Yanhong Zhu Method of treating and preventing alzheimer disease through administration of delipidated protein and lipoprotein particles
DK2368565T3 (en) * 2003-07-03 2015-09-28 Hdl Therapeutics Inc Enrichment of pre-beta lipoproteins, high density
US7393826B2 (en) * 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
EP1996940B1 (en) 2006-02-09 2011-12-21 University of South Florida Detection of cancer by elevated levels of bcl-2
US8414846B2 (en) * 2007-09-11 2013-04-09 University Of Florida Research Foundation, Inc. Devices and methods for the collection and detection of substances
US9360398B2 (en) 2007-09-11 2016-06-07 University Of Florida Research Foundation, Inc. Devices and methods for the collection and detection of substances
US9207242B2 (en) 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
JP2021504003A (ja) 2017-11-22 2021-02-15 エイチディーエル セラピューティクス インコーポレイテッドＨｄｌ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 血漿処理システムの流体回路をプライミングするシステムおよび方法
CA3087207A1 (en) 2017-12-28 2019-07-04 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190496A (en) * 1971-05-14 1980-02-26 Syva Company Homogeneous enzyme assay for antibodies
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates
NL7802056A (nl) * 1977-03-14 1978-09-18 Hoffmann La Roche Bepaling van menselijk (beta)-lipotropine.
IL51668A (en) * 1977-03-16 1981-12-31 Israel State Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
FR2385099A1 (fr) * 1977-03-21 1978-10-20 Stago Diagnostica Methode de determination immuno-enzymologique
US4230805A (en) * 1977-04-15 1980-10-28 Syva Company Theophylline antigens and antibodies
US4241177A (en) * 1978-08-28 1980-12-23 Syva Company Propanolol antigen conjugates and antibodies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS618665A (ja) * 1984-03-09 1986-01-16 コンパニ・オリ・アンデユストリ・ソシエテ・アノニム 抗原、抗体、またはハプテンの免疫検定法、この免疫検定法を用いたリポ蛋白質、およびα−フエトプロテインの検定法、およびこの検定法を実施する検定キツト

Also Published As

Publication number Publication date
GB2061501A (en) 1981-05-13
SE450861B (sv) 1987-08-03
SE8008952L (sv) 1980-12-18
WO1980002460A1 (fr) 1980-11-13
GB2061501B (en) 1983-09-14
FR2455743A1 (fr) 1980-11-28
US4399217A (en) 1983-08-16

Similar Documents

Publication Publication Date Title
DE2924198C2 (ja)
BR8002583A (ja)
FR2446411B3 (ja)
DE3048773C2 (ja)
BR8006808A (ja)
DE3004710C2 (ja)
DE2931071C2 (ja)
FR2447204B1 (ja)
DE2901611C2 (ja)
FR2446631B1 (ja)
FR2446354B1 (ja)
JPS55170754U (ja)
DE2936470C2 (ja)
AU78391S (ja)
AU79200S (ja)
AU79557S (ja)
AU78569S (ja)
AU79559S (ja)
AU79826S (ja)
AU79918S (ja)
AU79950S (ja)
AU80228S (ja)
AU78390S (ja)
BR5901094U (ja)
BG28728A1 (ja)